Study of pro and anti-apoptotic genes to understand the resistance of apoptosis mediated by Bcr-Abl (2007)
- Authors:
- USP affiliated authors: CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; MENDES, JOAO GUSTAVO PESSINI AMARANTE - ICB
- Unidades: FCFRP; ICB
- Subjects: APOPTOSE; DOENÇA CRÔNICA; MEDULA ÓSSEA; LEUCEMIA; IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: Ribeirão Preto
- Date published: 2007
- Source:
- Título do periódico: Applied Cancer Research
- Volume/Número/Paginação/Ano: v. 27, n. 2, p. 73, res. PT.080, 2007
- Conference titles: São Paulo Research Conferences - Cancer 2007
-
ABNT
FIGUEIREDO-BARROS, B. et al. Study of pro and anti-apoptotic genes to understand the resistance of apoptosis mediated by Bcr-Abl. Applied Cancer Research. Ribeirão Preto: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 24 abr. 2024. , 2007 -
APA
Figueiredo-Barros, B., Bueno-da-Silva, A. E. B., Castro, F. A. de, Amarante-Mendes, J. G. P., & Jacysyn, J. F. (2007). Study of pro and anti-apoptotic genes to understand the resistance of apoptosis mediated by Bcr-Abl. Applied Cancer Research. Ribeirão Preto: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. -
NLM
Figueiredo-Barros B, Bueno-da-Silva AEB, Castro FA de, Amarante-Mendes JGP, Jacysyn JF. Study of pro and anti-apoptotic genes to understand the resistance of apoptosis mediated by Bcr-Abl. Applied Cancer Research. 2007 ; 27( 2): 73.[citado 2024 abr. 24 ] -
Vancouver
Figueiredo-Barros B, Bueno-da-Silva AEB, Castro FA de, Amarante-Mendes JGP, Jacysyn JF. Study of pro and anti-apoptotic genes to understand the resistance of apoptosis mediated by Bcr-Abl. Applied Cancer Research. 2007 ; 27( 2): 73.[citado 2024 abr. 24 ] - Conversion of CD95 (Fas) type II into type I signaling by sub-lethal doses of cycloheximide
- Development and characterization of murine models of T lymphoma to investigate the impact of oncogene expression
- Cosmomycin D, an anthracycline more potent than Doxorubicin for induction of tumor cell death, synergize with imatinib mesilate to induce apoptosis in Bcr-Abl-positive cells
- T lymphoma murine models to study the impact of ectopic expression of anti-apoptotic oncogenes
- BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia
- Indoleamine 2,3-dioxygenase expression in chronic myelogenous leukemia patients: association with disease progression
- Apoptotic genes expression in head and neck squamous cell carcinoma (HNSCC) patients
- Expression of pro-apoptotic bid and bik genes is decreased in chronic myeloid leukemia and low levels of bik MRNA are associated with lack of response to imatinib treatment
- BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients
- Down regulation of Hematopoietic SH2 domain containing (HSH2D) in the progression of the chronic myelogenous leukemia
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
